Paper Details

  1. Home
  2. Paper Details

Triptans and migraine: advances in use, administration, formulation, and development.

Author: MaconeAmanda E, PerloffMichael D

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Recent triptan research for migraine treatment focuses on new administration methods, combination therapies, menstrual-related migraines, and novel serotonin receptor subtype agonists. While advancements in combination therapies and administration devices offer benefits like ease of use, efficacy, and reduced side effects, newer agents have comparable or even lower efficacy than generic triptans. While new agents targeting 5HTf receptors minimize vascular side effects, adverse reactions may limit their clinical use. Long-acting triptans, frovatriptan and naratriptan, show promise in treating menstrual-related migraines. Although newer triptans offer potential benefits, they come at a higher cost compared to generic options.
Paper Details　
Original Abstract of the Article :
Recent triptan development has focused on new administration methods and formulations, triptan combination therapies, treatment in menstrually related migraines, and novel serotonin receptor subtype agonists (5HTf). Areas covered: Clinical triptan research related to migraine was reviewed, analyzing...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/14656566.2017.1288721

データ提供：米国国立医学図書館（NLM）

Triptans for Migraine: A Journey Through Treatment Advancements

Migraine headaches can be [a real headache] for those who experience them, impacting their daily lives. This research delves into the world of [triptans], a class of medications commonly used for treating migraine. Researchers have been investigating ways to make triptans [more effective and easier to use]. This review analyzes recent studies to understand the latest developments in triptan therapy.

Navigating the Triptan Landscape: New Strategies for Migraine Management

The review highlights significant advances in [triptan therapy], including new delivery methods, combination therapies, and even new drug targets. It appears that researchers are working tirelessly to [tame the migraine beast] and provide more effective treatment options for patients. This research provides a comprehensive overview of the current landscape, offering valuable information for both patients and healthcare providers.

Managing Migraine Headaches: A Personalized Approach

Understanding the different types of triptans and their [unique advantages and limitations] is crucial for making informed treatment decisions. This research provides a helpful guide for [navigating the complex world of migraine treatment], empowering patients to work with their doctors to find the most effective and personalized approach.

Dr.Camel's Conclusion

This research reminds us that the [quest for migraine relief] is a continuous one, and the scientific community is constantly working to find better solutions. The advancements highlighted in this review offer hope for [those living with migraine] and demonstrate the power of research in improving our understanding of complex conditions.

Date :
  1. Date Completed 2017-03-10
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28129702

DOI: Digital Object Identifier

10.1080/14656566.2017.1288721

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.